Interleukin-35 attenuates collagen-induced arthritis through suppression of vascular endothelial growth factor and its receptors

International Immunopharmacology

Volumn 34, Issue , 2016, Pages 71-77

  Wua, Suqin ^a,b   Li, Yunxia ^a   Li, Yuxuan ^a   Yao, Lutian ^a   Lin, Tiantian ^a   Jiang, Shenyi ^a   Shen, Hui ^a   Xia, Liping ^a   Lu, Jing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Vocational College of Medicine   (China)

Author keywords

Collagen induced arthritis; Interleukin 35; Rheumatoid arthritis; Vascular endothelial growth factor

Indexed keywords

EOSIN; GAMMA INTERFERON; HEMATOXYLIN; INTERLEUKIN 35; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR; FLT1 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, MOUSE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A; VON WILLEBRAND ANTIGEN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; ARTICULAR INDEX; CONTROLLED STUDY; DOWN REGULATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INVESTIGATIVE PROCEDURES; MALE; MOUSE; MUSCULOSKELETAL DISEASE ASSESSMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; RIGIDITY; SYNOVITIS; SYNOVIUM; WESTERN BLOTTING; ANIMAL; DBA MOUSE; DISEASE MODEL; EXPERIMENTAL ARTHRITIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKINS; MALE; MICE; MICE, INBRED DBA; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VON WILLEBRAND FACTOR;

EID: 84959138523     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2016.02.018     Document Type: Article

References (29)

1. D.L. Scott, F. Wolfe, and T.W. Huizinga Rheumatoid arthritis Lancet 376 2010 1094 1108 (London, England)
2. T. Kasama, J. Yamazaki, R. Hanaoka, Y. Miwa, Y. Hatano, K. Kobayashi, M. Negishi, H. Ide, and M. Adachi Biphasic regulation of the development of murine type II collagen-induced arthritis by interleukin-12: possible involvement of endogenous interleukin-10 and tumor necrosis factor alpha Arthritis Rheum. 42 1999 100 109
3. N. Ferrara, K. Houck, L. Jakeman, and D.W. Leung Molecular and biological properties of the vascular endothelial growth factor family of proteins Endocr. Rev. 13 1992 18 32
4. H.R. Kim, K.W. Kim, B.M. Kim, M.L. Cho, and S.H. Lee The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis PLoS One 10 2015 e0124909
5. S.A. Yoo, H.J. Yoon, H.S. Kim, C.B. Chae, S. De Falco, C.S. Cho, and W.U. Kim Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation Arthritis Rheum. 60 2009 345 354
6. A. Giatromanolaki, E. Sivridis, N. Athanassou, E. Zois, P.E. Thorpe, R.A. Brekken, K.C. Gatter, A.L. Harris, I.M. Koukourakis, and M.I. Koukourakis The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis J. Pathol. 194 2001 101 108
7. W. Niedbala, X.Q. Wei, B. Cai, A.J. Hueber, B.P. Leung, I.B. McInnes, and F.Y. Liew IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells Eur. J. Immunol. 37 2007 3021 3029
8. X. Sha, S. Meng, X. Li, H. Xi, M. Maddaloni, D.W. Pascual, H. Shan, X. Jiang, H. Wang, and X.F. Yang Interleukin-35 inhibits endothelial cell activation by suppressing MAPK-AP-1 pathway J. Biol. Chem. 290 2015 19307 19318
9. L.W. Collison, C.J. Workman, T.T. Kuo, K. Boyd, Y. Wang, K.M. Vignali, R. Cross, D. Sehy, R.S. Blumberg, and D.A. Vignali The inhibitory cytokine IL-35 contributes to regulatory T-cell function Nature 450 2007 566 569
10. R.X. Wang, C.R. Yu, I.M. Dambuza, R.M. Mahdi, M.B. Dolinska, Y.V. Sergeev, P.T. Wingfield, S.H. Kim, and C.E. Egwuagu Interleukin-35 induces regulatory B cells that suppress autoimmune disease Nat. Med. 20 2014 633 641
11. O. Devergne, M. Hummel, H. Koeppen, M.M. Le Beau, E.C. Nathanson, E. Kieff, and M. Birkenbach A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes J. Virol. 70 1996 1143 1153
12. T. Hamza, J.B. Barnett, and B. Li Interleukin 12 a key immunoregulatory cytokine in infection applications Int. J. Mol. Sci. 11 2010 789 806
13. F. Karlsson, N.E. Martinez, L. Gray, S. Zhang, I. Tsunoda, and M.B. Grisham Therapeutic evaluation of ex vivo-generated versus natural regulatory T-cells in a mouse model of chronic gut inflammation Inflamm. Bowel Dis. 19 2013 2282 2294
14. Y. Li, Y. Wang, Y. Liu, Y. Wang, X. Zuo, Y. Li, and X. Lu The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease Mediat. Inflamm. 2014 2014 136329
15. J.Q. Liu, Z. Liu, X. Zhang, Y. Shi, F. Talebian, J.W. Carl Jr., C. Yu, F.D. Shi, C.C. Whitacre, J. Trgovcich, and X.F. Bai Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis J. Immunol. 188 2012 3099 3106
16. R.M. Pope, and S. Shahrara Possible roles of IL-12-family cytokines in rheumatoid arthritis Nat. Rev. Rheumatol. 9 2013 252 256
17. T. Kasama, R.M. Strieter, N.W. Lukacs, P.M. Lincoln, M.D. Burdick, and S.L. Kunkel Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis J. Clin. Invest. 95 1995 2868 2876
18. D.A. Vignali, and V.K. Kuchroo IL-12 family cytokines: immunological playmakers Nat. Immunol. 13 2012 722 728
19. A.E. Koch, L.A. Harlow, G.K. Haines, E.P. Amento, E.N. Unemori, W.L. Wong, R.M. Pope, and N. Ferrara Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis J. Immunol. 152 1994 4149 4156
20. M.M. Ally, B. Hodkinson, P.W. Meyer, E. Musenge, G.R. Tintinger, M. Tikly, and R. Anderson Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis BMC Musculoskelet. Disord. 16 2015 130
21. L. Klareskog, D. van der Heijde, J.P. de Jager, A. Gough, J. Kalden, M. Malaise, E. Martin Mola, K. Pavelka, J. Sany, L. Settas, J. Wajdula, R. Pedersen, S. Fatenejad, and M. Sanda Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial Lancet 363 2004 675 681 (London, England)
22. H.P. Gerber, T.H. Vu, A.M. Ryan, J. Kowalski, Z. Werb, and N. Ferrara VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation Nat. Med. 5 1999 623 628
23. B. Muz, M.N. Khan, S. Kiriakidis, and E.M. Paleolog Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis Arthritis Res. Ther. 11 2009 201
24. D. Shweiki, A. Itin, D. Soffer, and E. Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843 845
25. L.F. Brown, B. Berse, K. Tognazzi, E.J. Manseau, L. Van de Water, D.R. Senger, H.F. Dvorak, and S. Rosen Vascular permeability factor mRNA and protein expression in human kidney Kidney Int. 42 1992 1457 1461
26. M. Feldmann, F.M. Brennan, B.M. Foxwell, and R.N. Maini The role of TNF alpha and IL-1 in rheumatoid arthritis Curr. Dir. Autoimmun. 3 2001 188 199
27. G.S. Marchand, N. Noiseux, J.F. Tanguay, and M.G. Sirois Blockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors Am. J. Physiol. Heart Circ. Physiol. 282 2002 H194 H204
28. Y.S. Lin, C. Nguyen, J.L. Mendoza, E. Escandon, D. Fei, Y.G. Meng, and N.B. Modi Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor J. Pharmacol. Exp. Ther. 288 1999 371 378
29. J. Lu, H. Shen, P.T. Yang, W.G. Xiao, and L.J. Zhao [Effect of neutralizing anti-VEGF antibody on genesis of murine type II collagen-induced arthritis] Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 21 2005 748 750